Skip to main content
. 2020 May 15;12(5):569–581. doi: 10.4251/wjgo.v12.i5.569

Table 3.

Univariate analysis of prognostic factors for 200 intraperitoneally-disseminated gastric cancer patients

n 1-yr survival, % Median survival in mo P value
Gender
Male 121 18.4 5.2 0.4
Female 79 18.5 6.5
Age
< 60 100 21.1 6.5 0.26
60+ 100 15.4 5.0
Borrmann’s type
I-II 22 34.3 6.8 0.13
III-IV 178 16.5 5.2
Ascites
Absence 113 29.5 6.9 < 0.0001
Presence 87 1.7 4.0
Histology
G1 5 0 3.6 0.64
G2 12 40 6.8
G3 54 13.5 5.6
G4 98 21.2 5.2
Signet ring 24 9.5 6.5
Mucinous 3 0 3.7
Extraperitoneal metastases
No 165 19.7 6.4 0.031
Yes 34 7.7 4.2
JGCA classification
P0 (Cyt+) 4 0 4.0 < 0.0001
P1 46 47.2 9.8
P2 40 18.8 6.7
P3 110 5.1 4.0
PCI
0 (Cyt+) 4 0 4.0 < 0.0001
1-6 64 39.8 8.5
7-12 25 6.7 4.2
13+ 104 5.5 4.1
Lymph node dissection
D0, 1 35 31.4 7.5 0.61
D1+, 2 9 50.0 8.9
Cytoreduction score
CC-0 9 22.2 7.5 0.065
CC-1 19 58.2 13.1
CC-2 16 18.8 4.7

JGCA: Japanese Gastric Cancer Association; PCI: Peritoneal cancer index; CC: Completeness of cytoreduction.